joint prosthesis has allowed the opportunity for these patients, who are not candidates for a below-knee amputation, to have improved ambulation compared to the traditional above-knee prosthesis. Objectives: Social media is changing the way the world communicates, including the world of medicine. Physicians are increasingly engaging in platforms such as Twitter to discuss interesting cases, share recent journal articles, and further disease awareness. While many interventional radiologists and cardiologists have adopted Twitter as a means of communication, little is known about the contribution by vascular surgeons. The aim of this study was to evaluate vascularrelated key phrases on Twitter to determine vascular surgeon involvement in social media.
surgeons (Fig 1). Cardiologists (112 tweets [22%]), interventional radiologists (91 tweets [18%]), and interventional neurologists (92 tweets [18%])
all had greater usage of #endovascular. When evaluating keywords related to peripheral artery disease (#PADawareness, #peripheralartery-disease, #limbsalvage), vascular surgeons contributed 26 (10%) of a total 259 tweets (Fig 2) . Medical device companies and industry were the dominant contributors, with 113 tweets (44%).
Conclusions: In this study we evaluated keywords that are highly relevant to our field to determine the participation of vascular surgery in social media. We found that vascular surgery presence was lacking compared to other specialties and individuals. As these platforms continue to expand with open discussion of medical information, it is important for vascular surgeons to be active participants.
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Infected Pseudoaneurysms Is Catastrophic in Intravenous Drug Abusers
Rami Srouji, Hanaa N. Dakour Aridi, Satinderjit S. Locham, Besma J. Nejim, Mahmoud B. Malas. Johns Hopkins University School of Medicine, Baltimore, Md Objectives: Intravenous drug abusers (IVDAs) are at an increased risk of developing infected peripheral pseudoaneurysms. The aim of this study is to describe a population of IVDAs with infected peripheral pseudoaneurysms and to assess the outcomes of vascular surgery reconstruction in this population.
Methods: A retrospective study of the Premier Database 2009 to 2015 was performed. All IVDA patients with an admitting or primary International Classification of Diseases-9 Revision diagnosis code of infected pseudoaneurysms were identified. The characteristics and comorbidities of this population, along with the vascular procedures performed and in hospital complications, were described.
Results: A total of 18,793 vascular surgery patients who are known to be IVDAs were identified. Of this population, 98 patients (0.5%) presented with infected peripheral pseudoaneurysms. The mean age of this population was 44.9 (standard deviation, 14.0) years, with 66.3% white, 7.1% African American, 2.0 % Hispanic, and 24.5 % other ethnicities. This population presented mainly from the South (34.7%), followed by the West (28.6%), Northeast (19.4%), and Midwest (17.3%). The majority of these patients were covered by Medicaid (49.0%), while some had Medicare coverage (16.7%). The most common comorbidities were chronic obstructive pulmonary disease (22.5%) and congestive heart failure (12.2%; Table I ). The majority of patients underwent resection of upper and lower limb arteries (33.7%), aneurysm repair/resection (18.0%), and bypass (13.5%). Primary major amputation was done in two patients (2.3%). The in-hospital mortality rate was 1.0%. The most common in-hospital complications included hemorrhage/shock (14.3%), respiratory failure (5.1%), graft-related (4.1%), and wound complications (4.1%; Table II) . Four patients (4.1%) underwent concomitant secondary major amputation during the same hospitalization. Median hospital length of stay was 8 days. Half of those patients were discharged home, while the rest were discharged to a skilled nursing facility or a rehabilitation center (23.7%), transferred to a general hospital (5.2%), or home under home health service organization (13.4%). The median cost of hospitalization for these patients was $21,291 (U.S.) with a median fixed and variable cost of $8960 (U.S.) each.
Conclusions: This study describes an unusual population, which poses a huge medical, social, and economic burden. IVDAs who present with infected pseudoaneurysms are at high risk for postoperative complications and major morbidity. Approximately 6% of these patients end up losing their limbs. These patients stay in the hospital for long time, and when discharged, they are likely not going home. The resources invested to care for these patients could be better allocated in helping them sustain drug free status and preventing this catastrophic complication. Objectives: This study reports the outcomes of hybrid revascularization combining iliofemoral endarterectomy and iliac artery stenting using covered stents in TASC C and D aortoiliac occlusive disease involving femoral bifurcation.
Methods: A retrospective review was conducted of patients with TASC C and D aortoiliac occlusive disease undergoing hybrid revascularization between December 2009 and July 2016 at a single academic center. Demographics, indications for surgery, lesion classification and location, stent location and type, length of stay (LOS), 90-day morbidity and mortality, and patency were assessed. Primary outcomes were hemodynamic success (defined as an increase in the ipsilateral ankle-brachial index [ABI] of at least 0.1), clinical success (improved symptoms of claudication, rest pain, or wound healing) at 30 days, and patency. All patients underwent a preoperative and follow-up ABI and pulse volume recording (PVR).
Results: Thirty-six male patients, mean age 63.9 6 6.0 years, underwent revascularization of 41 limbs (TASC C: 39%; D: 61%). There were no significant differences in demographics, comorbidities, or indications between TASC C and D patients. Indications for surgery were claudication (27%), rest pain (44%), or tissue loss (29%). Mean operative time was 340 6 100 minutes with estimated blood loss 500 mL (275-1000 mL). Seventy-seven stents were placed (66 covered, 11 bare metal). Covered stents were used primarily, and bare-metal stents were used at the iliac bifurcation to preserve internal iliac artery patency. All external iliac arteries were treated with covered stents. Simultaneous adjunctive procedures (5 infrainguinal bypasses, 3 superficial femoral artery stents) were performed in 22%. Ninety-day complications included 1 pulmonary embolus, 1 pneumonia, 4 surgical-site infections, 2 hematomas, 3 seromas, 1 stent thrombosis, 1 femoral artery pseudoaneurysm, and 1 infected covered stent. Hospital and intensive care unit LOS were 4 days (3-6 days) and 2 days (2-3 days), respectively. All patients with available data experienced 30-day clinical and hemodynamic success. Mean follow-up was 23 months 
